Clinical Trial Update: Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA [NA]

View source ↗

Summary

This completed clinical trial evaluates middle meningeal artery embolization using TRUFILL n-BCA for chronic subdural hematoma, with results posted in 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRUFILL n-BCA (n-butyl cyanoacrylate)

Snippet

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. | Conditions: Chronic Subdural Hematoma | NA | Status: COMPLETED | Results posted: 2026-02-24